John & Joann
Well-known member
Knight-Rider recently published a report regarding Amiodarone. It is not approved for Atrial Fib/Flutter. Read the attached article and also the link.
Use of amiodarone comes with substantial risks
Knight Ridder Newspapers
What are amiodarone's risks?
The drug's FDA-approved prescribing label for doctors, which patients rarely see, warns that the drug comes with "substantial toxicity." About three-fourths of all patients taking a 400 mg dose experienced some side effects. Some can be fatal:
-Lung toxicity, which has harmed as many as 17 percent of patients in some studies and has been fatal about 10 percent of the time.
-Liver injury is common. While usually mild, it too can be fatal.
-Worsening of the heart rhythm problem.
-When given to pregnant women, the drug has caused serious harm to the fetus. Other side effects include thyroid problems and neurological disorders. Vision problems and blindness also have been reported.
Should patients take amiodarone for atrial fibrillation?
The FDA hasn't approved amiodarone to treat atrial fibrillation. However, as with all drugs, doctors are free to prescribe it "off label" after weighing the risks and benefits.
According to the latest research, particularly a major National Institutes of Health study called AFFIRM, experts say amiodarone generally isn't the first drug a patient should try for atrial fibrillation. A patient should first try a drug to regulate how fast the heart beats.
Other options include a procedure to destroy the misfiring electrical connection in the heart. Patients also can be treated with various rhythm-control drugs.
What can patients do?
Talk with your doctor. Ask why he or she chose rhythm control over rate control. For more information about the AFFIRM study, go to www.nhlbi.nih.gov/new/press/02-12-04.htm.
Don't stop taking amiodarone without a doctor's supervision.
Make sure your doctor regularly monitors you for signs of lung, liver and thyroid problems.
Ask your pharmacist for a copy of the official, FDA-approved prescribing label - not just the one-page sheet that pharmacies often hand out with drugs. Or read the label online at www.cordarone.com.
http://www.nhlbi.nih.gov/new/press/02-12-04.htm
There has been a significant amount of information released in the past 3 weeks.
Do NOT stop with your medication until you have consulted with your physician. They may NOT have read this latest information. This information is VERY RECENT NEWS!!!
The ambulance chasers already have sites on the internet to find clients.
Use of amiodarone comes with substantial risks
Knight Ridder Newspapers
What are amiodarone's risks?
The drug's FDA-approved prescribing label for doctors, which patients rarely see, warns that the drug comes with "substantial toxicity." About three-fourths of all patients taking a 400 mg dose experienced some side effects. Some can be fatal:
-Lung toxicity, which has harmed as many as 17 percent of patients in some studies and has been fatal about 10 percent of the time.
-Liver injury is common. While usually mild, it too can be fatal.
-Worsening of the heart rhythm problem.
-When given to pregnant women, the drug has caused serious harm to the fetus. Other side effects include thyroid problems and neurological disorders. Vision problems and blindness also have been reported.
Should patients take amiodarone for atrial fibrillation?
The FDA hasn't approved amiodarone to treat atrial fibrillation. However, as with all drugs, doctors are free to prescribe it "off label" after weighing the risks and benefits.
According to the latest research, particularly a major National Institutes of Health study called AFFIRM, experts say amiodarone generally isn't the first drug a patient should try for atrial fibrillation. A patient should first try a drug to regulate how fast the heart beats.
Other options include a procedure to destroy the misfiring electrical connection in the heart. Patients also can be treated with various rhythm-control drugs.
What can patients do?
Talk with your doctor. Ask why he or she chose rhythm control over rate control. For more information about the AFFIRM study, go to www.nhlbi.nih.gov/new/press/02-12-04.htm.
Don't stop taking amiodarone without a doctor's supervision.
Make sure your doctor regularly monitors you for signs of lung, liver and thyroid problems.
Ask your pharmacist for a copy of the official, FDA-approved prescribing label - not just the one-page sheet that pharmacies often hand out with drugs. Or read the label online at www.cordarone.com.
http://www.nhlbi.nih.gov/new/press/02-12-04.htm
There has been a significant amount of information released in the past 3 weeks.
Do NOT stop with your medication until you have consulted with your physician. They may NOT have read this latest information. This information is VERY RECENT NEWS!!!
The ambulance chasers already have sites on the internet to find clients.